Please login to the form below
The Medicines Company
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of The Medicines Company's 2013 cardiovasular sales performance.
Novartis scores CHMP backing for cholesterol drug Leqvio
Potential first-in-class treatment moves closer to EU approval. Novartis has been granted a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use ... Novartis picked up Leqvio following its $9.7bn
Cortellis Drugs to Watch in 2020 report
The three from this year’s list are: Valrox, which if approved, would become the first gene therapy for any form of haemophilia; Inclisiran, from The Medicines Company, which could become ... 8. Inclisiran from The Medicines Company (now a Novartis
Novartis plans inclisiran trial in the UK
The announcement was made on the same day that the company officially opened its new headquarters in White City, London. ... Novartis acquired inclisiran from The Medicines Company, after a completing a $9.7bn takeover of the company.
Cosentyx, Entresto drive topline growth for Novartis in Q4
According to the company, the momentum of the neprilysin inhibitor was driven by a higher demand in ambulatory settings. ... These new drugs are expected to continue to drive growth into 2020 – newly acquired cholesterol drug inclisiran, gained from
Novartis links up with NHS for speedy access to cholesterol drug inclisiran
Novartis gained inclisiran from its $9.7bn acquisition of the drug's developer The Medicines Company, which completed last week. ... watchdog NICE once it receives approval from the European Medicines Agency (EMA).
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Future of MHRA uncertain amid Brexit-fuelled shake up
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- David Hunt launches independent agency The Considered
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
- Accelerating Drug Development Timelines with Big Data Analytics
- A Lucid Group Thirsty Thursday Special: Beautiful Rejects
- EU “still interested” in Valneva COVID vaccine despite UK snub
- US orders 1.4 million more doses of Regeneron antibody cocktail
- Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Live Webinar: Making Actionable Health Information More Accessible Through Point-of-Care Testing
- Ovid wins Communiqué Small Consultancy of the Year award at Communiqué 2021
- Future of MHRA uncertain amid Brexit-fuelled shake up
- Lucid Group celebrates a double win at Communiqué 2021
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To transform lives through communication that changes behaviour and improves health outcomes....
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
